Full case includes Shepard's, Headnotes, Legal Analytics from Lex Machina, and more.
915 F.3d 743 *; 2019 U.S. App. LEXIS 3645 **; 129 U.S.P.Q.2D (BNA) 1339 ***
ATHENA DIAGNOSTICS, INC., OXFORD UNIVERSITY INNOVATION LTD., MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V., Plaintiffs-Appellants v. MAYO COLLABORATIVE SERVICES, LLC, DBA MAYO MEDICAL LABORATORIES, MAYO CLINIC, Defendants-Appellees
Subsequent History: As Amended February 14, 2019.
Rehearing denied by, Rehearing, en banc, denied by Athena Diagnostics, Inc. v. Mayo Collaborative Servs., LLC, 927 F.3d 1333, 2019 U.S. App. LEXIS 19979 (Fed. Cir., July 3, 2019)
US Supreme Court certiorari denied by Athena Diagnostics v. Collaborative, 2020 U.S. LEXIS 24 (U.S., Jan. 13, 2020)
Prior History: [**1] Appeal from the United States District Court for the District of Massachusetts in No. 1:15-cv-40075-IT, Judge Indira Talwani.
Athena Diagonistics, Inc. v. Mayo Collaborative Servs., LLC, 275 F. Supp. 3d 306, 2017 U.S. Dist. LEXIS 123412 (D. Mass., Aug. 4, 2017)
natural law, patent, steps, autoantibodies, inventive, label, diagnostic, recite, detecting, district court, conventional, antibody, eligibility, laws of nature, specification, discovery, bodily fluid, immunoprecipitation, ineligible, patients, patent-eligible, epitope, argues, radioimmunoassay, radioactive, man-made, subject matter, iodination, technology, patent law
Civil Procedure, Appeals, Standards of Review, De Novo Review, Patent Law, Subject Matter, Defenses, Demurrers & Objections, Motions to Dismiss, Failure to State Claim, Judgments, Summary Judgment, Motions for Summary Judgment, Reviewability of Lower Court Decisions, Preservation for Review